Familial tendency and risk of nasopharyngeal carcinoma in taiwan: effects of covariates on risk

In the present study, the authors compared the long-term risk of nasopharyngeal carcinoma (NPC) of male participants in an NPC multiplex family cohort with that of controls in a community cohort in Taiwan after adjustment for anti-Epstein-Barr virus (EBV) seromarkers and cigarette smoking. A total o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of epidemiology 2011-02, Vol.173 (3), p.292-299
Hauptverfasser: Hsu, Wan-Lun, Yu, Kelly J, Chien, Yin-Chu, Chiang, Chun-Ju, Cheng, Yu-Juen, Chen, Jen-Yang, Liu, Mei-Ying, Chou, Sheng-Ping, You, San-Lin, Hsu, Mow-Ming, Lou, Pei-Jen, Wang, Cheng-Ping, Hong, Ji-Hong, Leu, Yi-Shing, Tsai, Ming-Hsui, Su, Mao-Chang, Tsai, Sen-Tien, Chao, Wen-Yuan, Ger, Luo-Ping, Chen, Peir-Rong, Yang, Czau-Siung, Hildesheim, Allan, Diehl, Scott R, Chen, Chien-Jen
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:In the present study, the authors compared the long-term risk of nasopharyngeal carcinoma (NPC) of male participants in an NPC multiplex family cohort with that of controls in a community cohort in Taiwan after adjustment for anti-Epstein-Barr virus (EBV) seromarkers and cigarette smoking. A total of 43 incident NPC cases were identified from the 1,019 males in the NPC multiplex family cohort and the 9,622 males in the community cohort, for a total of 8,061 person-years and 185,587 person-years, respectively. The adjusted hazard ratio was 6.8 (95% confidence interval (CI): 2.3, 20.1) for the multiplex family cohort compared with the community cohort. In the evaluation of anti-EBV viral capsid antigen immunoglobulin A and anti-EBV deoxyribonuclease, the adjusted hazard ratios were 2.8 (95% CI: 1.3, 6.0) and 15.1 (95% CI: 4.2, 54.1) for those positive for 1 EBV seromarker and positive for both seromarkers, respectively, compared with those negative for both EBV seromarkers. The adjusted hazard ratio was 31.0 (95% CI: 9.7, 98.7) for participants who reported a family history of NPC and who were anti-EBV-seropositive compared with individuals without such a history who were anti-EBV-seronegative. The findings suggest that both family history of NPC and anti-EBV seropositivity are important determinants of subsequent NPC risk and that the effect of family history on NPC risk cannot be fully explained by mediation through EBV serologic responses.
ISSN:0002-9262
1476-6256
DOI:10.1093/aje/kwq358